CN Patent

CN102190594A — 阿戈美拉汀氯化氢水合物及其制备方法

Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2011-09-21 · 15y expired

What this patent protects

本发明涉及式I的阿戈美拉汀氯化氢水合物及其制备方法。本发明方法得到的阿戈美拉汀卤化氢水合物溶解性比阿戈美拉汀有显著提高，适合成品药物制剂时的应用需要；且产品稳定性好、纯度高。在制备工艺上也非常简便，无需特殊的操作，即可得到高纯度的产品。 X＝Cl。

USPTO Abstract

本发明涉及式I的阿戈美拉汀氯化氢水合物及其制备方法。本发明方法得到的阿戈美拉汀卤化氢水合物溶解性比阿戈美拉汀有显著提高，适合成品药物制剂时的应用需要；且产品稳定性好、纯度高。在制备工艺上也非常简便，无需特殊的操作，即可得到高纯度的产品。 X＝Cl。

Drugs covered by this patent

Patent Metadata

Patent number
CN102190594A
Jurisdiction
CN
Classification
—
Expires
2011-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Pharmaceutical Industry
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.